Insider · CIK 0001364708
Mark J Costa
Files at IFF (INTERNATIONAL FLAVORS & FRAGRANCES INC), EMN (EASTMAN CHEMICAL CO). First filing Nov 27, 2024, latest Aug 28, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EMN: EASTMAN CHEMICAL CO
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 66Notable | EASTMAN CHEMICAL CO | $502k 7,400 shares | +2% | +17% from low-38% from high | |
| 43Moderate | EASTMAN CHEMICAL CO | $484k 4,834 shares | -1% | - | |
| 50Moderate | EASTMAN CHEMICAL CO | $1.9M 18,278 shares | -4% | - | |
| 55Moderate | EASTMAN CHEMICAL CO | $9.4M 89,732 shares | -23% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2025 | EMN EASTMAN CHEMICAL CO | POpen-market purchase Common Stock | +7,400 | $67.89 | $502k | 453,986 | Aug 28, 2025 |
| May 1, 2025 | IFF INTERNATIONAL FLAVORS & FRAGRANCES INC | MOption exercise Common Stock | +1,875 | $0.00 | $0 | 4,014 | May 5, 2025 |
| May 1, 2025 | IFF INTERNATIONAL FLAVORS & FRAGRANCES INC | MOption exercise Restricted Stock Unitsderivative | -1,875 | $77.85 | $146k | 0 | May 5, 2025 |
| May 1, 2025 | IFF INTERNATIONAL FLAVORS & FRAGRANCES INC | AGrant or award Restricted Stock Unitsderivative | +2,569 | $0.00 | $0 | 2,569 | May 5, 2025 |
| Feb 26, 2025 | EMN EASTMAN CHEMICAL CO | MOption exercise Common Stock | +4,834 | $65.16 | $315k | 451,420 | Feb 28, 2025 |
| Feb 26, 2025 | EMN EASTMAN CHEMICAL CO | SOpen-market sale Common Stock | -4,834 | $100.08 | $484k | 446,586 | Feb 28, 2025 |
| Feb 26, 2025 | EMN EASTMAN CHEMICAL CO | MOption exercise Employee Stock Option (right to buy)derivative | -4,834 | $0.00 | $0 | 48,649 | Feb 28, 2025 |
| Feb 20, 2025 | EMN EASTMAN CHEMICAL CO | AGrant or award Employee Stock Option (right to buy)derivative | +121,458 | $0.00 | $0 | 121,458 | Feb 24, 2025 |
| Feb 20, 2025 | EMN EASTMAN CHEMICAL CO | AGrant or award Restricted Stock Unitsderivative | +23,195 | $0.00 | $0 | 23,195 | Feb 24, 2025 |
| Feb 18, 2025 | EMN EASTMAN CHEMICAL CO | AGrant or award Common Stock | +81,525 | $0.00 | $0 | 477,224 | Feb 20, 2025 |
| Feb 18, 2025 | EMN EASTMAN CHEMICAL CO | FTax withholding Common Stock | -30,638 | $103.47 | $3.2M | 446,586 | Feb 20, 2025 |
| Nov 29, 2024 | EMN EASTMAN CHEMICAL CO | MOption exercise Common Stock | +18,278 | $65.16 | $1.2M | 413,977 | Dec 3, 2024 |
| Nov 29, 2024 | EMN EASTMAN CHEMICAL CO | SOpen-market sale Common Stock | -18,278 | $105.00 | $1.9M | 395,699 | Dec 3, 2024 |
| Nov 29, 2024 | EMN EASTMAN CHEMICAL CO | MOption exercise Employee Stock Option (right to buy)derivative | -18,278 | $0.00 | $0 | 53,483 | Dec 3, 2024 |
| Nov 26, 2024 | EMN EASTMAN CHEMICAL CO | MOption exercise Common Stock | +2,224 | $65.16 | $145k | 397,923 | Nov 27, 2024 |
| Nov 26, 2024 | EMN EASTMAN CHEMICAL CO | SOpen-market sale Common Stock | -2,224 | $105.63 | $235k | 395,699 | Nov 27, 2024 |
| Nov 26, 2024 | EMN EASTMAN CHEMICAL CO | MOption exercise Common Stock | +87,508 | $65.16 | $5.7M | 483,207 | Nov 27, 2024 |
| Nov 26, 2024 | EMN EASTMAN CHEMICAL CO | SOpen-market sale Common Stock | -87,508 | $105.01 | $9.2M | 395,699 | Nov 27, 2024 |
| Nov 26, 2024 | EMN EASTMAN CHEMICAL CO | MOption exercise Employee Stock Option (right to buy)derivative | -2,224 | $0.00 | $0 | 159,269 | Nov 27, 2024 |
| Nov 26, 2024 | EMN EASTMAN CHEMICAL CO | MOption exercise Employee Stock Option (right to buy)derivative | -87,508 | $0.00 | $0 | 71,761 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.